What Does the UK's Office of Fair Trading Really Think of Direct-to-Pharmacy Distribution?
February 2008RAJ Pharma
The UK's Office of Fair Trading seems to be in something of a quandary as to the benefits of the direct-to-pharmacy distribution networks that some pharmaceutical manufacturers have introduced.
On one hand, the OFT sees DTP schemes as something that must, almost inevitably, have a negative impact on the pricing and provision of medicinal products in the UK. On the other hand, it acknowledges, possibly grudgingly, that DTP schemes provide some benefits, particularly as regards protection of patients against counterfeits.